Crossmark

Predicting survival of patients with advanced hepatocellular carcinoma receiving combination targeted immunotherapy: an evaluation of volumetric imaging parameters

Crossref DOI link: https://doi.org/10.1007/s00261-024-04257-0

Published Online: 2024-03-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mohseni, Alireza

Baghdadi, Azarakhsh

Madani, Seyedeh Panid

Shahbazian, Haneyeh

Mirza-Aghazadeh-Attari, Mohammad

Borhani, Ali

Afyouni, Shadi

Zandieh, Ghazal

Baretti, Marina

Kim, Amy K.

Yarchoan, Mark

Kamel, Ihab R. https://orcid.org/0000-0001-7927-6912
License Information

Text and Data Mining valid from 2024-03-28

Version of Record valid from 2024-03-28
More Information

Article History

Received: 5 November 2023

Revised: 14 February 2024

Accepted: 16 February 2024

First Online: 28 March 2024

Declarations

:

: The authors declare no conflicts of interest and no financial support or funding was received for this study.

Document is current

Any future updates will be listed below